Ubrogepant is a medication used for the treatment of migraines. However, during the manufacturing process of ubrogepant, impurities may be formed which can affect the quality and safety of the final product. These impurities need to be identified and characterized to ensure that the medication is safe for human consumption. The presence of impurities can also impact the efficacy of the medication, so it is important to monitor and control their levels during the manufacturing process.
